Juun 16-17, 2023, MedGence waxay ka qaybgashay Shirka Horumarinta Tayada Sare ee Warshadaha Daryeelka Caafimaadka & Shirwaynaha 8-aad ee Hal-abuurka Dawooyinka Shiinaha ee R&D, kaas oo si guul leh loogu qabtay Chongqing.
MedGence waxaa lagu sharfay mid ka mid ah "2023 Top 20 R&D CRO Enterprises ee Shiinaha"!
Ugu horreyntii, xafladda furitaanka, "2022 China Pharmaceutical R&D Strength Ranking" liisaska taxanaha ah ayaa la sii daayay waxaana MedGence lagu sharfay mid ka mid ah "2023 Top 20 Pharmaceutical CRO Enterprises ee Shiinaha"!
The "2023 Pharmaceutical CRO Enterprises ee Shiinaha" waxaa doortay guddiga CRO Ranking Expert Review oo ku salaysan 10 tilmaamayaasha iyo cabbirro kala duwan, sida wadarta dakhliga sanadlaha ah (dakhliga hawlgalka), kobaca dakhliga sanadlaha ah (%), faa'iidada saafiga ah, kobaca faa'iidada saafiga ah (%), R&D maalgashiga, R&D kobaca maalgashiga (%), size shaqaalaha, kobaca size shaqaalaha (dhibcaha), aqoonta calaamadda iwm. Hal-joojin TCM shirkadda horumarinta dawooyinka cusub, ayaa ku guulaysatay abaalmarinta "2023 Top 20 Pharmaceutical CRO Enterprises ee Shiinaha", waxay muujisay awooddeeda iyo xooggeeda.
Waqtigan xaadirka ah, hogaamiyaha TCM CXO, Dr. Yi Yueneng, Guddoomiyaha & Maamulaha Guud ee MedGence, ayaa lagu martiqaaday inuu ka soo qayb galo Shirwaynaha Sideedaad ee Shiinaha Pharmaceutical R & D Innovation wuxuuna jeediyay khudbad ku saabsan "Bilawga Dhamaadka - Xeeladaha Horumarinta Daawooyinka Cusub ee Shiinaha". Waxay tilmaantay in wakhtigan la dardar geliyey lana hagaajiyey naqshadaynta heerka sare ee horumarinta dawooyinka Shiinaha, deegaanka siyaasaddana si joogto ah loo wanaajiyey, taageeradana la kordhiyey, daawaynta Shiinuhuna ay baal dahab ah ka gashay. Waxay sidoo kale xalliyey deegaanka siyaasadda, cilmi-baarista iyo geeddi-socodka horumarinta, iyo codsiga xaaladda horumarinta warshadaha dawooyinka dhaqanka Shiinaha ee waaga cusub, muujisay xiriirka macquulka ah gudaha, falanqeeyay dhibaatooyinka muuqda in weli ka jira horumarinta hadda ee warshadaha dawooyinka dhaqanka Shiinaha, iyo soo jeediyay tallaabooyin ka hortag ah oo macquul ah.
Kadib, Dr. Yi Yueneng, oo ah martigeliyaha madasha wareega wareega ee "Ma guga dawada Shiinaha ee cusub ee R&D Soo socota", waxay si wadajir ah uga wadahadleen isbeddellada iyo caqabadaha R&D iyo hal-abuurka daawada Shiinaha ee ciyaartoyda warshadaha. Sida isku-duwaha ugu weyn, MedGence wuxuu had iyo jeer ku qotomaa warshadaha dawooyinka, si firfircoon u sahaminta, si joogto ah u cusbooneysiiya, kor u qaadida horumarinta warshadaha, iyo sii wadida u adeegida shirkadaha dawooyinka ee dhammaan Shiinaha.
Shir madaxeedka ayaa soo jiitay hoggaamiyeyaal badan oo duurka ku xeeran dawooyinka, kulliyadaha iyo jaamacadaha, machadyada cilmi-baarista, shirkadaha dawooyinka, unugyada R & D iyo kuwa kale oo badan si ay uga qayb qaataan warbixinnada mawduucyada ku xeeran R & D ee dawooyinka Chinese dhaqanka, hal-abuurka diyaarinta, xeerarka iyo siyaasadaha, tayada iyo badbaadada, habaynta habka, qalab cusub, teknoolajiyada cusub iyo kulan kale oo kulul, iyo mid ka mid ah inta lagu guda jiro kulan heer sare ah. oo ka mid ah bandhigayaasha gaarka ah ee dhacdada, waxay leedahay booth gaar ah, taas oo soo jiidatay saaxiibo badan oo ka mid ah warshadaha si ay u soo booqdaan! Inta lagu guda jiro shirwaynaha, iyada oo ka mid ah bandhigayaasha lagu martiqaaday, Enable Pharma waxay lahayd rug gaar ah, taas oo soo jiidatay saaxiibo badan oo warshadeed si ay u booqdaan rugta wadatashiga, xiriir dhow oo lala yeesho shirkadaha waaweyn ee daawooyinka, iyo xiritaanka baahida cilmi baarista iyo horumarinta daroogada.
Waqtiga boostada: Jul-15-2023